Prediction of irinotecan pharmacokinetics by use of cytochrome P450 3A4 phenotyping probes.
Mathijssen RH, de Jong FA, van Schaik RH, Lepper ER, Friberg LE, Rietveld T, de Bruijn P, Graveland WJ, Figg WD, Verweij J, Sparreboom A.
Mathijssen RH, et al. Among authors: verweij j.
J Natl Cancer Inst. 2004 Nov 3;96(21):1585-92. doi: 10.1093/jnci/djh298.
J Natl Cancer Inst. 2004.
PMID: 15523087